NCT07223320

Brief Summary

This single-arm pilot study will assess the feasibility and preliminary effectiveness of an intensive motor skill intervention (HABIT-ILE) combined with functional strength training (FST) in children with SMA who are receiving disease-modifying therapies. Participants will attend one 6-hour HABIT-ILE + FST session each weekend (Saturday or Sunday) for 15 weeks, for a total of 90 hours of training. Feasibility will be evaluated through questionnaires, and effectiveness through standardized motor function assessments.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable

Timeline
14mo left

Started Oct 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress34%
Oct 2025Jul 2027

First Submitted

Initial submission to the registry

September 25, 2025

Completed
6 days until next milestone

Study Start

First participant enrolled

October 1, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 31, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2027

Last Updated

March 16, 2026

Status Verified

September 1, 2025

Enrollment Period

1.2 years

First QC Date

September 25, 2025

Last Update Submit

March 13, 2026

Conditions

Keywords

HABIT-ILEFunctional strength trainingPediatricRehabilitationMotor controlIntensive

Outcome Measures

Primary Outcomes (1)

  • Feasibility questionnaire

    Feasibility questionnaire completed by both the child and their parents to assess the acceptability of the intervention (including child satisfaction and physical comfort, and parent feedback), as well as its demand and practicality.

    Immediately after the intervention

Secondary Outcomes (11)

  • Hammersmith Functional Motor Scale -Expanded (HFMSE)

    4 assessments: Baseline 1, baseline 2 (1 week), post intervention (16 weeks), 3 months follow-up

  • Revised Upper Limb Module (RULM)

    4 assessments: Baseline 1, baseline 2 (1 week), post intervention (16 weeks), 3 months follow-up

  • Endurance Shuttle box and blocks test (ESBBT)

    4 assessments: Baseline 1, baseline 2 (1 week), post intervention (16 weeks), 3 months follow-up

  • 6-Minute Walk Test (6MWT)

    4 assessments: Baseline 1, baseline 2 (1 week), post intervention (16 weeks), 3 months follow-up

  • 10 Meter Walking Test (10MWT)

    4 assessments: Baseline 1, baseline 2 (1 week), post intervention (16 weeks), 3 months follow-up

  • +6 more secondary outcomes

Study Arms (1)

Combined HABIT-ILE + FST

EXPERIMENTAL

Participants receive a combined intervention consisting of Hand-Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) and Functional Strength Training (FST). Both components are delivered as an integrated, intensive motor learning-based program aimed at improving upper and lower limb function in children with SMA .Subject will participate in a HABIT-ILE + FST camp format for 6 hours/day, one day/week for 15 weeks.

Other: Combined Hand-Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) + functional strength training (FST)

Interventions

Goal-directed, task-specific training for both the upper and lower extremity, and postural control with targeted strengthening exercises to enhance motor control and facilitate the achievement of functional goals

Combined HABIT-ILE + FST

Eligibility Criteria

Age5 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Diagnosis of SMA
  • Able to participate in all pre and post intervention assessments
  • Able to understand and speak English
  • Able to understand directions (no significant cognitive delay or serious behavioral issues that would limit participation)
  • Receiving a stable dose of disease-modifying therapies for at least 6 months prior to enrollment.

You may not qualify if:

  • Orthopedic surgery within the last year (confound)
  • Initiation of any new pharmaceutical treatment during the study period
  • Participation in a clinical trial of an investigational therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for Cerebral Palsy Research, Teachers College, Columbia University

New York, New York, 10027, United States

Location

Related Publications (3)

  • Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, Mazzone ES, Vitale M, Snyder B, Quijano-Roy S, Bertini E, Davis RH, Meyer OH, Simonds AK, Schroth MK, Graham RJ, Kirschner J, Iannaccone ST, Crawford TO, Woods S, Qian Y, Sejersen T; SMA Care Group. Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. 2018 Feb;28(2):103-115. doi: 10.1016/j.nmd.2017.11.005. Epub 2017 Nov 23.

    PMID: 29290580BACKGROUND
  • Bleyenheuft Y, Gordon AM. Hand-arm bimanual intensive therapy including lower extremities (HABIT-ILE) for children with cerebral palsy. Phys Occup Ther Pediatr. 2014 Nov;34(4):390-403. doi: 10.3109/01942638.2014.932884. Epub 2014 Oct 1.

    PMID: 25271469BACKGROUND
  • Bleyenheuft Y, Ebner-Karestinos D, Surana B, Paradis J, Sidiropoulos A, Renders A, Friel KM, Brandao M, Rameckers E, Gordon AM. Intensive upper- and lower-extremity training for children with bilateral cerebral palsy: a quasi-randomized trial. Dev Med Child Neurol. 2017 Jun;59(6):625-633. doi: 10.1111/dmcn.13379. Epub 2017 Jan 30.

    PMID: 28133725BACKGROUND

MeSH Terms

Conditions

Muscular Atrophy, Spinal

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesMotor Neuron DiseaseNeurodegenerative DiseasesNeuromuscular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 25, 2025

First Posted

October 31, 2025

Study Start

October 1, 2025

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

July 1, 2027

Last Updated

March 16, 2026

Record last verified: 2025-09

Locations